docusate has been researched along with oxybutynin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Manome, Y; Nishida, N; Sawabe, T; Taniyama, K | 1 |
| Hong, M; Li, J; Qi, MH; Ren, GB; Wang, K; Wang, Q | 1 |
2 other study(ies) available for docusate and oxybutynin
| Article | Year |
|---|---|
Development and evaluation of a monolithic drug-in-adhesive patch for valsartan.
Topics: Administration, Cutaneous; Angiotensin II Type 1 Receptor Blockers; Animals; Dioctyl Sulfosuccinic Acid; Excipients; Female; Humans; Male; Mice; Mice, Hairless; Myristates; Permeability; Rats; Rats, Hairless; Skin Absorption; Species Specificity; Swine; Swine, Miniature; Tetrazoles; Transdermal Patch; Valine; Valsartan | 2010 |
Transdermal Delivery of Metformin Utilizing Ionic Liquid Technology: Insight Into the Relationship Between Counterion Structures and Properties.
Topics: Administration, Cutaneous; Delayed-Action Preparations; Dioctyl Sulfosuccinic Acid; Hypoglycemic Agents; Ionic Liquids; Metformin; Skin; Skin Absorption; Transdermal Patch | 2022 |